Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 1 , Pages 75-85 , March 2007

A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T Cells

  • Tarek M. Fahmy, PhD

      Affiliations

    • Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA
    • Corresponding Author InformationCorresponding author. Malone Engineering Center, Yale University, New Haven, CT 06511.
    • ,
  • Jonathan P. Schneck, PhD

      Affiliations

    • Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    • ,
  • W. Mark Saltzman, PhD

      Affiliations

    • Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA

Received 18 August 2006 ,Accepted 21 November 2006.

References 

  1. Klenerman P, Cerundolo V, Dunbar PR. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol. 2002;2(4):263–272
  2. Howard MC, Spack EG, Choudhury K, Greten TF, Schneck JP. MHC-based diagnostics and therapeutics—clinical applications for disease-linked genes. Immunol Today. 1999;20(4):161–165
  3. Schwartz RH. T cell anergy. Annu Rev Immunol. 2003;21:305–334
  4. Casares S, Stan AC, Bona CA, Brumeanu TD. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera. Nat Biotechnol. 2001;19(2):142–147
  5. Garcia KC, Tallquist MD, Pease LR, Brunmark A, Scott CA, Degano M, et al. αβ T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A. 1997;94(25):13838–13843
  6. Fremont DH, Rees WA, Kozono H. Biophysical studies of T-cell receptors and their ligands. Curr Opin Immunol. 1996;8(1):93–100
  7. Fahmy TM, Bieler JG, Schneck JP. Probing T cell membrane organization using dimeric MHC-Ig complexes. J Immunol Methods. 2002;268(1):93–106
  8. Luo D, Haverstick K, Belcheva N, Han E, Saltzman WM. Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery. Macromolecules. 2002;35(9):3456–3462
  9. Schneck JP. Monitoring antigen-specific T cells using MHC-Ig dimers. Immunol Invest. 2000;29(2):163–169
  10. Schneck JP, Slansky JE, Herrin SMO, Greten TF. Monitoring antigen-specific T cells using MHC-Ig dimers. In: New York: Wiley; 2000;p. 17.2.1–17.2.17
  11. Kruisbeek AM, Shevach EM. In vitro assays for mouse lymphocyte function. In: Current protocols in immunology. In: Current protocols in immunology. New York: Wiley; 2004;p. 3.12-1–3.12-20[Section III: Assays for T cell Function]
  12. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6(8):427–436
  13. D'Emanuele A, Attwood D. Dendrimer-drug interactions. Adv Drug Deliv Rev. 2005;57(15):2147–2162
  14. Jansen JFGA, de Brabander-van den Berg EM, Meijer EW. Encapsulation of guest molecules into a dendritic box. Science. 1994;266(5188):1226–1229
  15. Jansen JFGA, Meijer EW, de Brabander-van den Berg EMM. The dendritic box–shape-selective liberation of encapsulated guests. J Am Chem Soc. 1995;117(15):4417–4418
  16. Kobayashi H, Brechbiel MW. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol Imaging. 2003;2(1):1–10
  17. Dennig J, Duncan E. Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. J Biotechnol. 2002;90(3-4):339–347
  18. Yoo H, Sazani P, Juliano RL. PAMAM dendrimers as delivery agents for antisense oligonucleotides. Pharm Res. 1999;16(12):1799–1804
  19. Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Bioconjug Chem. 1999;10(1):103–111
  20. Tomalia DA, Naylor AM, Goddard WA. Starburst dendrimers—molecular-level control of size, shape, surface-chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl. 1990;29(2):138–175
  21. Sykulev Y, Brunmark A, Tsomides TJ, Kageyama S, Jackson M, Peterson PA. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A. 1994;91(24):11487–11491
  22. Dunbar PR, Ogg GS. Oligomeric MHC molecules and their homologues: state of the art. J Immunol Methods. 2002;268(1):3–7
  23. Gerweck LE, Kozin SV, Stocks SJ. The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells. Br J Cancer. 1999;79(5-6):838–842
  24. Roos A. Weak acids, weak bases, and intracellular pH. Respir Physiol. 1978;33:27–30
  25. Sykulev Y, Vugmeyster Y, Brunmark A, Ploegh HL, Eisen HN. Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. Immunity. 1998;9(4):475–483
  26. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274(5284):94–96
  27. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, et al. The immunological synapse. Annu Rev Immunol. 2001;19:375–396
  28. Belcheva N, Baldwin SP, Saltzman WM. Synthesis and characterization of polymer-(multi)-peptide conjugates for control of specific cell aggregation. J Biomat Sci Polym Ed. 1998;9(3):207–226
  29. Belcheva N, Woodrow-Mumford K, Mahoney MJ, Saltzman WM. Synthesis and biological activity of polyethylene glycol–mouse nerve growth factor conjugate. Bioconjug Chem. 1999;10(6):932–937
  30. Katre N. The conjugation of proteins with polyethylene glycol and other polymers. Altering properties of proteins to enhance their therapeutic potential. Adv Drug Delivery Rev. 1993;10:91–114

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(06)00345-5

doi: 10.1016/j.nano.2006.11.010

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 1 , Pages 75-85 , March 2007

Article Tools

* Image Usage & Resolution